Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
The new study, published in The Lancet, is the first to evaluate a once-yearly injection of an HIV pre-exposure prophylaxis ...
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops the ...
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
A yearly injection to protect against HIV is safe and shows promise as a prevention method with long-lasting effects, according to the results of a clinical trial published in The Lancet journal.
Medpage Today on MSN14h
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
AllAfrica on MSN1d
Africa: U.S. Funding Cuts Imperil Search for HIV VaccineBlog - A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback